March 2024
-
03.12.2024
November 2023
-
11.02.2023
Research and Pipeline Research Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual Meeting
June 2023
-
06.26.2023
Research and Pipeline Research Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus
-
06.01.2023
December 2022
-
12.29.2022
-
12.01.2022
Financial Finance Medicines Research Vaccines Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day
-
12.01.2022
October 2022
-
10.04.2022
Research and Pipeline Research Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial
September 2022
-
09.19.2022
Research and Pipeline Research Vaccines Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union
-
09.14.2022
Research and Pipeline Research Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
August 2022
-
08.08.2022
Research and Pipeline Research Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
June 2022
-
06.17.2022